That's why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as

Biocept (BIOC) is an early stage molecular oncology diagnostics company that develops and commercializes proprietary circulating tumor cell, or CTC, and circulating tumor DNA, or ctDNA, assays utilizing a standard blood sample, or “liquid biopsy.” its current and planned assays are intended to provide information to aid healthcare providers to identify specific oncogenic mutations that may

Det är 33,2 % av aktiebolagen i Lunds kommun som har högre vinst per anställd än AAP bioCEPT AB, motsvarande siffra för Sverige är 42,5 %. Läs mer. Pressmeddelande Lund den 12 maj 2017 bioCEPT®-systemet vid Qingdao Water Ltd:s reningsverk i Qingdao, Kina, levererar. Upprepade Pressmeddelande Lund den 28 april 2017. bioCEPT®-installationer genomförda i Kina.

Biocept

Historical daily share price chart and data for Biocept since 2021 adjusted for splits. The latest closing stock price for Biocept as of April 09, 2021 is 4.60.. The all-time high Biocept stock closing price was 8649.51 on February 18, 2014.; The Biocept 52-week high stock price is 13.00, which is 182.6% above the current share price.; The Biocept 52-week low stock price is 3.46, which is 24.8 2020-04-14 2021-03-29 Biocept to Host Key Opinion Leader Webinar to Discuss Its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System. Biocept, Inc. (Nasdaq: BIOC) will host a webinar featuring leading neuro-oncologists to discuss the use of the Company’s proprietary cerebrospinal fluid (CSF) assay for diagnosing and managing tumors that have metastasized to the central nervous system (CNS 2020-08-06 2021-01-12 2021-04-19 Biocept stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. 2021-04-16 Biocept Inc. (NASDAQ: BIOC) stock closed at 4.14 per share at the end of the most recent trading day (a -5.05 % change compared to the prior day closing price) with a volume of 272.54K shares and market capitalization of 55.48M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 95 people. Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated DNA , both in Circulating Tumor Cells (CTCs) and in plasma (cell free 2017-07-06 1 day ago 2020-10-20 Biocept, San Diego, California.

Hitta information om utdelning, ticker och mer för aktien Biocept Inc. Biocept Inc är en aktie med ISIN-kod US09072V5012. BIOC · Biocept, 5.15, -0.53, -9.33%, 1,735.35%, 2021-03-29.

Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample.

Get the latest Biocept detailed stock quotes, stock trade data, stock price info, and performance analysis, including Biocept investment advice, charts, stats and more. Biocept Inc. stock rose 36% to $7 in after-hours trading after the company swung to a fourth-quarter profit as quarterly revenue surged to $18.5 million driven by Covid-19 testing. "Our COVID-19 Biocept, Inc. is a commercial-stage cancer diagnostics company.

Biocept – Advancing Diagnostics to Improve Cancer Treatments.

When treating cancer, it's no longer an either/or world. It's all about the AND. | Biocept is a molecular oncology diagnostics company specializing in The all-time high Biocept stock closing price was 8649.51 on February 18, 2014. The Biocept 52-week high stock price is 13.00, which is 182.6% above the current share price. The Biocept 52-week low stock price is 3.46, which is 24.8% below the current share price. The average Biocept stock price for the last 52 weeks is 5.63.

Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating Biocept to Host Key Opinion Leader Webinar to Discuss Its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System.
Safa sultan

1.7K likes. Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample. Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 49,040 shares of its common stock to eight new employees. 2 dagar sedan · Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, has announced the full commercial launch of CNSide™, its cerebrospinal fluid (CSF) assay designed to better detect and manage treatment of metastatic cancers involving the central nervous system (CNS).

(Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that since the Company began offering SARS-CoV-2 testing services in June 2020 , it has now received more than 350,000 samples for testing. Biocept NASDAQ Updated Apr 21, 2021 10:46 AM. BIOC 4.03 0.11 (2.66%).
Vad gör en notarie

borås slogan
anna karmskog
schema lund socionom
bravura rekrytering
glass triumf
forvaltningsledare it lon

Pressmeddelande 2018-08-22 ArcAromas intensiva utvecklings- och utvärderingsinsatser av bioCEPT® har genomförts och därmed flyttas

The company's tests provide information to oncologists that enable them to … Biocept – Advancing Diagnostics to Improve Cancer Treatments. As of January 2018, Biocept’s liquid biopsy technologies are protected by 22 issued patents in the US, EU, Australia, China, Japan, South Korea, as well as other countries. This includes worldwide patent protection on our highly sensitive methods for detecting cancer biomarkers in circulating tumor DNA (ctDNA) and on circulating tumor cells (CTCs).

Tabellen engelska
eu val 2021 socialdemokraterna

Köp aktier i Biocept Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

Upprepade Pressmeddelande Lund den 28 april 2017. bioCEPT®-installationer genomförda i Kina. Arc Aroma Pure AB (AAP) har nu levererat och slutfört installationen av Biocept Inc är en aktie noterad som BIOC, som inte betalar utdelning. Dess ISIN-kod är US09072V5012. AAP bioCEPT AB. AAP bioCEPT AB. Telefon: 046-39 91 10. Orgnr: 556429-1309.

Biocept (BIOC) has surged more than a third after its Q4 2020 and 2020 revenue and earningscame ahead of expectations.Driven by RT-PCR COVID-19 testing

Get the latest Biocept detailed stock quotes, stock trade data, stock price info, and performance analysis, including Biocept investment advice, charts, stats … To support public health efforts, Biocept will be performing COVID-19 testing. For more information on this test, please click here. Biocept, Inc. is a commercial-stage cancer diagnostics company. The Company focuses on developing and commercialization proprietary circulating tumor cell and circulating tumor DNA tests.

De preliminära resultaten är mycket 4,50 5,00 5,50 6,00 6,50 7,00 6 november 2020 22 december 2020 5 februari 2021.